^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Sarcoma |
| Drug: | Halaven (eribulin mesylate) (Microtubule inhibitor, CBP inhibitor, β-catenin inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Uterine sarcoma: Systemic therapy for uterine sarcoma…Other recommended regimens…Eribulin (category 2B)
